Clinical trial
Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected…
NCT00252291 · Syntara, Industry · Completed
Key facts
| NCT number | NCT00252291 |
|---|---|
| Title | Ability of Aridol to Detect Bronchial Hyperresponsiveness in Suspected Asthmatics |
| Official title | A Phase III Multicenter Study to Demonstrate the Sensitivity and Specificity of Aridol (Mannitol) Challenge to Predict Bronchial Hyperresponsiveness as Manifested by a Positive Exercise Challenge in Subjects Presenting With Signs and Symptoms Suggestive of Asthma But Without a Definitive Diagnosis |
| Lead sponsor | Syntara, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Asthma |
| Intervention type | Drug, Procedure |
| Interventions | Aridol, Methacholine, Exercise challenge |
| Enrollment | 240 |
| Start date | Nov 1, 2005 |
| Completion | Sep 1, 2006 |
| First posted | Nov 11, 2005 |
| Last update posted | Dec 1, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: